Avita Medical | 销售和管理费用



金融业
股票价格
AUD
资产
AUD 58.13M
现金及等价物
AUD 12.22M
销售成本
AUD 3.47M
流动资产
AUD 36.25M
流动负债
AUD 62.6M
债务
AUD 44.59M
EBIT
AUD -8.66M
EBITDA
AUD -21.9M
员工
AUD 87
EPS每股收益
AUD -0.38
股本和储备
AUD -12.89M
销售毛利
AUD 14.95M
债务利息支出
AUD 1.25M
贷款资金
AUD 42.25M
市值
AUD 167.89M
净收入
AUD -9.92M
营业费用
AUD 29.57M
营业利润
AUD -11.15M
税前利润
AUD -23.77M
销售收入
AUD 18.42M
销售和管理费用
AUD 20.98M
股票
AUD 7.54M
贸易债权人
AUD 7.27M
应收帐款人
AUD 11.37M


销售和管理费用 更改 日
Accuray USD 127.32M 500.16M 2025-09
Celltrion KRW 249.98B 16.36B 2025-09
Clinuvel Pharmaceuticals AUD 9.12M 6.2M 2025-06
Cochlear AUD 234.95M 235.05M 2025-06
CSL USD 727M 453M 2025-06
Cspc Pharmaceutical CNY 1.97B 404.66M 2025-09
Deva Holding AS TRY 462.26M 48.18M 2023-09
Dianthus Therapeutics USD 8.2M 669K 2025-09
Divis Laboratories Ltd INR 3.4B 10M 2025-06
Kangmei Pharma CNY 274.41M 15.05M 2025-09
Knight Therapeutics CAD 25.48M 119K 2024-09
Laboratorios Farma EUR 35.32M 2.75M 2025-06
Malin Corporation EUR 1.1M 400K 2024-12
Mayne Pharma AUD 54.8M 11.94M 2024-06
Medical Developments International AUD 7.03M 5.91M 2025-06
Nanosonics AUD 26.85M 23.41M 2025-06
Neuren Pharmaceuticals AUD 1.24M 1.09M 2025-06
Organigram Holdings CAD 8.86M 499K 2025-09
Ovoca Bio EUR 2.96M 8K 2022-06
Pacific Edge NZD 19.17M 1.32M 2025-12
Paradigm Biopharmaceuticals AUD 1.61M 747.79K 2025-06
Pharma Mar EUR 13.7M 983K 2025-09
Polynovo AUD 21.13M 18.27M 2024-06
PYC Therapeutics AUD 2.13M 447.24K 2025-06
Qiagen NV USD 153.88M 10.77M 2025-12
Ramsay Health Care AUD 5.29B 3.2M 2024-12
ResMed USD 275.7M 16.51M 2025-12
Sartorius EUR 218.7M 6.5M 2025-09
Sino Biopharmaceutical CNY 7.54B 2.23B 2025-06
Telix Pharmaceuticals AUD 93.48M 1.04M 2025-12
Tilray USD 24.85M 1.7M 2025-09
Zz Pientze Pharmaceu CNY 171.91M 343.2M 2025-09


Avita Medical 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.